2,3,5,4‑tetrahydroxy diphenylethylene‑2‑O‑glucoside inhibits the adhesion and invasion of A549 human lung cancer cells

Xu,Ming; Wang,Cong; Zhu,Minglin; Wang,Xianguo; Zhang,Li; Zhao,Jinping

doi:10.3892/mmr.2017.7680

2,3,5,4‑tetrahydroxy diphenylethylene‑2‑O‑glucoside inhibits the adhesion and invasion of A549 human lung cancer cells

Authors:
- Ming Xu
- Cong Wang
- Minglin Zhu
- Xianguo Wang
- Li Zhang
- Jinping Zhao
View Affiliations

Affiliations: Department of Thoracic and Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China, Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: October 2, 2017 https://doi.org/10.3892/mmr.2017.7680
Pages: 8900-8906
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is considered to be a serious disease that poses a significant threat to human health. 2,3,5,4‑tetrahydroxy diphenylethylene‑2‑O‑glucoside (THSG) is a bioactive compound derived from Polygonum multiflorum Thunb. That has been demonstrated to possess antioxidative, anti‑inflammatory and antitumor activities. However, little is currently known regarding the potential anticancer effects of this compound in lung cancer. Therefore, the present study aimed to investigate the effects of THSG on the adhesion and invasion of A549 human lung cancer cells in vitro, and to identify the putative mechanisms involved. Cell Counting kit‑8 assay was performed to determine A549 cell viability following treatment with various doses (0, 5, 10, 25, 50, 100, 150 and 200 µM) of THSG for 12, 24 and 48 h. In addition, cell adhesion and invasion were determined following treatment of A549 cells with 0, 10, 25 or 50 µM THSG for 1, 2 or 3 h, respectively. Reverse transcription‑quantitative polymerase chain reaction analysis was performed to examine the mRNA expression levels of Snail, E‑cadherin, vimentin, matrix metalloproteinase (MMP) 2 and MMP9 following THSG treatment for 12 h. Western blot analysis was conducted to detect the protein expression levels of Snail, E‑cadherin, vimentin, MMP2 and MMP9 following THSG treatment for 24 h. Treatment with THSG (10, 25 and 50 µM) significantly suppressed the adhesion and invasion of A549 human lung cancer cells in a dose‑dependent manner. In addition, the mRNA and protein expression levels of adhesion and invasion‑associated factors were decreased significantly in A549 cells treated with THSG. In conclusion, THSG effectively suppressed the adhesion and invasion of human lung cancer cells potentially by inhibiting the expression of adhesion and invasion‑related genes.

View Figures

View References

1	Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q, Wang P, Wu S and Zhang JZ: Lung cancer mortality trends in China from 1988 to 2013: New Challenges and Opportunities for the Government. Int J Environ Res Public Health. 13:10522016. View Article : Google Scholar :
2	Sulu E, Tasolar O, Takir H Berk, Tuncer L Yagci, Karakurt Z and Yilmaz A: Delays in the diagnosis and treatment of non-small-cell lung cancer. Tumori. 97:693–697. 2011.PubMed/NCBI
3	Tamiya A, Naito T, Ono A, Ayabe E, Tsuya A, Nakamura Y, Kaira K, Murakami H, Takahashi T, Endo M and Yamamoto N: Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more. Lung Cancer. 71:173–177. 2011. View Article : Google Scholar : PubMed/NCBI
4	Vitzthum K, Thielke L, Deter A, Riemer T, Eggeling S, Pankow W and Mache S: Smoking lung cancer patients and tobacco Cessation-is the current treatment in Germany sufficient? Pneumologie. 69:667–672. 2015. View Article : Google Scholar : PubMed/NCBI
5	Milano MT, Strawderman RL, Venigalla S, Ng K and Travis LB: Non-small-cell lung cancer after breast cancer: A population-based study of clinicopathologic characteristics and survival outcomes in 3529 women. J Thorac Oncol. 9:1081–1090. 2014. View Article : Google Scholar : PubMed/NCBI
6	Abhishekh HA, Balaji AL and Mehta RM: Depression in lung cancer patients. Indian J Psychiatry. 56:3072014. View Article : Google Scholar : PubMed/NCBI
7	Asai N, Ohkuni Y, Matsuda M and Kaneko N: Small-cell lung cancer with epidermal growth factor receptor mutation: Case report and review of literature. Indian J Cancer. 51:384–385. 2014. View Article : Google Scholar : PubMed/NCBI
8	Chen ZF, Mao L, Liu LM, Liu YC, Peng Y, Hong X, Wang HH, Liu HG and Liang H: Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies. J Inorg Biochem. 105:171–180. 2011. View Article : Google Scholar : PubMed/NCBI
9	To KK, Au-Yeung SC and Ho YP: Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles. Anticancer Drugs. 17:673–683. 2006. View Article : Google Scholar : PubMed/NCBI
10	Huang HP, Gao SL, Wang J, Huang LQ and Huang P: Studies on adventitious root induction in vitro and suspension culture of Polygonum multiflorum. Zhongguo Zhong Yao Za Zhi. 38:3857–3860. 2013.(In Chinese). PubMed/NCBI
11	Lee SV, Choi KH, Choi YW, Hong JW, Baek JU, Choi BT and Shin HK: Hexane extracts of Polygonum multiflorum improve tissue and functional outcome following focal cerebral ischemia in mice. Mol Med Rep. 9:1415–1421. 2014. View Article : Google Scholar : PubMed/NCBI
12	Chan YC, Wang MF and Chang HC: Polygonum multiflorum extracts improve cognitive performance in senescence accelerated mice. Am J Chin Med. 31:171–179. 2003. View Article : Google Scholar : PubMed/NCBI
13	Chen Y, Wang M, Rosen RT and Ho CT: 2,2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum thunb. J Agric Food Chem. 47:2226–2228. 1999. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Xu M, Qian G, Xie F, Shi C, Yan L, Yu L, Zheng T, Wei L and Yang J: Expression of epithelial cell adhesion molecule associated with elevated ductular reactions in hepatocellar carcinoma. Clin Res Hepatol Gastroenterol. 38:699–705. 2014. View Article : Google Scholar : PubMed/NCBI
16	Yamada S, Utsunomiya T, Morine Y, Imura S, Ikemoto T, Arakawa Y, Kanamoto M, Iwahashi S, Saito Y, Takasu C, et al: Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol. 21 Suppl 3:S436–S442. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kim A, Kim EY, Cho EN, Kim HJ, Kim SK, Chang J, Ahn CM and Chang YS: Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer. Oncol Rep. 30:1423–1429. 2013. View Article : Google Scholar : PubMed/NCBI
18	Cogli L, Progida C, Bramato R and Bucci C: Vimentin phosphorylation and assembly are regulated by the small GTPase Rab7a. Biochim Biophys Acta. 1833:1283–1293. 2013. View Article : Google Scholar : PubMed/NCBI
19	Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mukai M and Okada Y: Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest. 91:1443–1458. 2011. View Article : Google Scholar : PubMed/NCBI
20	Muqbil I, Wu J, Aboukameel A, Mohammad RM and Azmi AS: Snail nuclear transport: The gateways regulating epithelial-to-mesenchymal transition? Semin Cancer Biol. 27:39–45. 2014. View Article : Google Scholar : PubMed/NCBI
21	Nawrocki-Raby B, Gilles C, Polette M, Martinella-Catusse C, Bonnet N, Puchelle E, Foidart JM, Van Roy F and Birembaut P: E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol. 163:653–661. 2003. View Article : Google Scholar : PubMed/NCBI
22	Wang J, Shi Q, Yuan TX, Song QL, Zhang Y, Wei Q, Zhou L, Luo J, Zuo G, Tang M, et al: Matrix metalloproteinase 9 (MMP-9) in osteosarcoma: Review and meta-analysis. Clin Chim Acta. 433:225–231. 2014. View Article : Google Scholar : PubMed/NCBI
23	Radenkovic S, Konjevic G, Jurisic V, Karadzic K, Nikitovic M and Gopcevic K: Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients. Cell Biochem Biophys. 68:143–152. 2014. View Article : Google Scholar : PubMed/NCBI
24	Flaws B: Cervical Dysplasia and Prostate Cancer Hpv, a Hidden Link: The Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Prostate Problems B. 1st edition. Blue Poppy Press; Boulder, CO: 1990
25	Wagner H and Ulrich-Merzenich G: Evidence and Rational Based Research on Chinese Drugs. Springer-Verlag; Wien: 2013, View Article : Google Scholar
26	Guo HM, Zhang XQ, Xu CH and Zou XP: Inhibition of invasion and metastasis of gastric cancer cells through snail targeting artificial microRNA interference. Asian Pac J Cancer Prev. 12:3433–3438. 2011.PubMed/NCBI
27	Golden DI, Lipson JA, Telli ML, Ford JM and Rubin DL: Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer. J Am Med Inform Assoc. 20:1059–1066. 2013. View Article : Google Scholar : PubMed/NCBI
28	Babiarz JC, Melaragni F, Kerr S and Kuchimanchi P: Confounding issues in cancer progress-the impact of investor requirements on senior management compensation and regulatory decisions: Tivozanib and Aveo Pharmaceuticals. Therapeu Innovation Regulatory Sci. 49:333–341. 2015. View Article : Google Scholar
29	Bae GY, Choi SJ, Lee JS, Jo J, Lee J, Kim J and Cha HJ: Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget. 4:2512–2522. 2013. View Article : Google Scholar : PubMed/NCBI
30	Bremnes RM, Veve R, Hirsch FR and Franklin WA: The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer. 36:115–124. 2002. View Article : Google Scholar : PubMed/NCBI
31	Wang J and Dong S: ICAM-1 and IL-8 are expressed by DEHP and suppressed by curcumin through ERK and p38 MAPK in human umbilical vein endothelial cells. Inflammation. 35:859–870. 2012. View Article : Google Scholar : PubMed/NCBI
32	Toda M, Kuo CH, Borman SK, Richardson RM, Inoko A, Inagaki M, Collins A, Schneider K and Ono SJ: Evidence that formation of vimentin mitogen-activated protein kinase (MAPK) complex mediates mast cell activation following FcεRI/CC chemokine receptor 1 cross-talk. J Biol Chem. 287:24516–24524. 2012. View Article : Google Scholar : PubMed/NCBI